Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Sets New 52-Week High – Here’s Why

Fresenius SE & Co. KGaA (OTCMKTS:FSNUYGet Free Report)’s share price hit a new 52-week high on Tuesday . The stock traded as high as $9.91 and last traded at $9.89, with a volume of 31150 shares traded. The stock had previously closed at $9.72.

Wall Street Analysts Forecast Growth

Separately, Citigroup upgraded Fresenius SE & Co. KGaA to a “strong-buy” rating in a research report on Friday, October 25th.

Get Our Latest Analysis on Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA Stock Performance

The company has a debt-to-equity ratio of 0.57, a current ratio of 1.36 and a quick ratio of 1.05. The stock’s 50-day simple moving average is $9.13 and its 200 day simple moving average is $9.10.

Fresenius SE & Co. KGaA Company Profile

(Get Free Report)

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

Recommended Stories

Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.